Anna Ravn Landtblom

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: LEUKEMIA. 2024;38(5):1081-1085
Childbirth rates in women with myeloproliferative neoplasms
Landtblom AR; Andersson TM-L; Johansson ALV; Lundberg FE; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):290
Modelling multiple time-scales with flexible parametric survival models
Batyrbekova N; Bower H; Dickman PW; Ravn Landtblom A; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(4):336-342
Survival and risk of vascular complications in myelofibrosis-A population-based study from the Swedish MPN group
Lindgren M; Andreasson B; Samuelsson J; Pettersson H; Enblom-Larsson A; Ravn-Landtblom A; Scheding S; Bentham C; Ahlstrand E
Article: LEUKEMIA. 2022;36(10):2461-2467
Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms-a nationwide population-based study of 342 pregnancies in Sweden
Landtblom AR; Andersson TM-L; Johansson ALV; Wendel SB; Lundberg FE; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: LEUKEMIA. 2021;35(2):476-484
Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients
Landtblom AR; Andersson TM-L; Dickman PW; Smedby KE; Eloranta S; Batyrbekova N; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(4):448-454
Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden
Hultcrantz M; Landtblom AR; Andreasson B; Samuelsson J; Dickman PW; Kristinsson SY; Bjorkholm M; Andersson TM-L
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;104(3):271-278
Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up
Ahlstrand E; Samuelsson J; Lindgren M; Pettersson H; Liljeholm M; Ravn-Landtblom A; Scheding S; Andreasson B
Article: LEUKEMIA. 2018;32(10):2203-2210
Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
Landtblom AR; Bower H; Andersson TM-L; Dickman PW; Samuelsson J; Bjorkholm M; Kristinsson SY; Hultcrantz M

Alla övriga publikationer

Editorial comment: HAEMATOLOGICA. 2023;108(7):1968-1971
Omalizumab alleviates pruritus in myeloproliferative neoplasms
Landtblom AR; Ungerstedt J; Hedlund A; Tobiasson M; Deneberg S; Jadersten M
Thesis / dissertation: 2023
Morbidity and childbirth in myeloproliferative neoplasms
Ravn Landtblom, Anna
Meeting abstract: BLOOD. 2016;128(22):946
Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden
Creignou M; Bower H; Andersson TM-L; Landtblom AR; Dickman PW; Bjorkholm M; Kristinsson SY; Hultcrantz M

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2024-2027

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2023
Läkarexamen, Karolinska Institutet, 2010
Medicine Magisterexamen, Karolinska Institutet, 2009

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI